Skip to content

Evaluation of the effectiveness of symptom control in patients with cancer

Evaluation of the effectiveness of symptom control in palliative care on the quality of life of cancer patients referred by oncologists

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230408057851N1
Enrollment
90
Registered
2023-05-07
Start date
2023-06-22
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced Cancer. Malignant neoplasm

Interventions

Intervention group: A personalized cancer symptom management plan, designed by a palliative medicine specialist, which includes pharmacological and non-pharmacological interventions (psychological, sp

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Having a definite cancer diagnosis with the opinion of an oncologist Physical and mental ability to communicate and complete questionnaires Having a score of at least 4 in one of the annoying symptoms such as pain or other physical symptoms Patient availability during the 2-week study period First referral to the palliative care service

Exclusion criteria

Exclusion criteria: The patient is in the final phase of the disease Prediction of survival of less than one month for the patient

Design outcomes

Primary

MeasureTime frame
The intensity score of common symptoms experienced by cancer patients in the Edmonton Symptom Assessment Scale questionnaire. Timepoint: Time intervals for evaluation at the beginning of the study (before the cancer symptom management plan), and by passing 7, and 14 days from the intervention (Follow-up). Method of measurement: Edmonton Symptom Assessment Scale questionnaire (ESAS).;Quality of life in cancer patients. Timepoint: Time intervals for evaluation at the beginning of the study (before the cancer symptom management plan), and by passing 7, and 14 days from the intervention (Follow-up). Method of measurement: The European Organization for Research and Treatment of Cancer core quality of life questionnaire (EORTC-QLQ-C??).

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAdeleh Rezagholizadeh Shirvan

Tehran University of Medical Sciences

adelehgholizadeh@gmail.com+98 21 6119 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026